Immunomedics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

IMMU 11.39 -0.19 (-1.64%)
price chart
Why Immunomedics, Inc. Jumped Higher Today
Immunomedics (NASDAQ:IMMU) is up 19% at 2:21 p.m. EST, after announcing a new CEO following the closing bell yesterday. The company also announced fiscal first-quarter earnings, but the jump in stock price is more likely to be related to the new ...
Analyst's Predictions on Immunomedics, Inc. (IMMU), Synchrony Financial (SYF)
Investors who are keeping close eye on the stock of Immunomedics, Inc. (NASDAQ:IMMU) established that the company was able to keep return on investment at - in the trailing twelve month while Reuters data showed that industry's average stands at -10.12 ...
Immunomedics Emerges With New Leadership
IMMU also adds Brendan Delaney, former Celgene V.P. Commercial from the same department, as CCO. IMMU-132 is showing tremendous promise in clinical trials for several oncology indications with unmet medical care needs.
Immunomedics Inc. (IMMU) Soars 5.31% on November 15  Equities.com
Highly Traded Stock: Immunomedics Inc. (IMMU)
The Stock had a 1 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.
Stock to Track: Immunomedics Inc (IMMU)  Post Registrar
Immunomedics Announces Presentations and Investor Event at the 2017 San ...
MORRIS PLAINS, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”) today announced that two of its abstracts were posted online at www.
Immunomedics Announces First Quarter Fiscal 2018 Results and Provides ...
MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”) today reported financial results for the first quarter ended September 30, 2017.
Immunomedics' (IMMU) Q1 2018 Results - Earnings Call Transcript  Seeking Alpha
Wells defends Immunomedics, 19% selloff a "buying opportunity"
Wells Fargo's Jim Birchenough says today's negative action for Immunomedics (IMMU -19.1%) is a "buying opportunity" after seeing an overview of abstract data on lead candidate IMMU-132 (sacituzumab govitecan), adding that the results support ...
Stocks Views And Recommendations: Immunomedics, Inc. (IMMU), Nielsen Holdings ...
Immunomedics, Inc. (NASDAQ:IMMU) shares were trading lower by -1.45 percent ($-0.17) at $11.58 a piece in Monday's session.
Immunomedics Inc. (IMMU) Moves Higher on Volume Spike for November 10
Immunomedics Inc. (IMMU) traded on unusually high volume on Nov. 10, as the stock gained 18.77% to close at $12.40. On the day, Immunomedics Inc. saw 8.08 million shares trade hands on 43,794 trades. Considering that the stock averages only a daily ...
Short Term Technical Outlook: The Kroger Co. (KR), Immunomedics, Inc. (IMMU)  Post Analyst
Hot Biotech stock to watch: Immunomedics, Inc.(NASDAQ: IMMU)  FX Daily Report
Immunomedics Inc (IMMU) Needle Moving on Volume
Immunomedics Inc (IMMU) shares are moving today on volatility -1.55% or -0.18 from the open. The NASDAQ listed company saw a recent bid of 11.40 and 733367 shares have traded hands in the session.